Your browser doesn't support javascript.
loading
Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter study.
Singal, Amit G; Ghaziani, T Tara; Mehta, Neil; Zhou, Kali; Grinspan, Lauren T; Benhammou, Jihane N; Moon, Andrew M; Yang, Ju Dong; Salgia, Reena; Pillai, Anjana; Zheng, Elizabeth; Rich, Nicole E; Gopal, Purva; Jalal, Prasun; Verna, Elizabeth; Yekkaluri, Sruthi; Phen, Samuel; Melendez-Torres, Jonathan; Alshuwaykh, Omar; Choi, Hailey; Junus, Kevin; Grady, John; Song, Michael; Leven, Emily A; Yum, Jung; Gowda, Vrushab; Alsudaney, Manaf; Hernandez, Perla; Desai, Nirmal; Parikh, Neehar D.
Afiliação
  • Singal AG; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Ghaziani TT; Department of Internal Medicine, Stanford University, Palo Alto, California, USA.
  • Mehta N; Department of Internal Medicine, University of California San Francisco, San Francisco, California, USA.
  • Zhou K; Department of Internal Medicine, University of Southern California, Los Angeles, California, USA.
  • Grinspan LT; Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Benhammou JN; Department of Internal Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Moon AM; Department of Internal Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Yang JD; Department of Internal Medicine, Cedar Sinai Medical Center, Los Angeles, California, USA.
  • Salgia R; Department of Internal Medicine, Henry Ford Medical Center, Detroit, Michigan, USA.
  • Pillai A; Division of Gastroenterology, Hepatology, and Nutrition, University of Chicago, Chicago, Illinois, USA.
  • Zheng E; Department of Internal Medicine, Columbia University, New York, New York, USA.
  • Rich NE; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Gopal P; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Jalal P; Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Verna E; Department of Internal Medicine, Columbia University, New York, New York, USA.
  • Yekkaluri S; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Phen S; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Melendez-Torres J; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Alshuwaykh O; Department of Internal Medicine, Stanford University, Palo Alto, California, USA.
  • Choi H; Department of Internal Medicine, University of California San Francisco, San Francisco, California, USA.
  • Junus K; Department of Internal Medicine, University of Southern California, Los Angeles, California, USA.
  • Grady J; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Song M; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Leven EA; Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Yum J; Department of Internal Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Gowda V; Department of Internal Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
  • Alsudaney M; Department of Internal Medicine, Cedar Sinai Medical Center, Los Angeles, California, USA.
  • Hernandez P; Department of Internal Medicine, Cedar Sinai Medical Center, Los Angeles, California, USA.
  • Desai N; Division of Gastroenterology, Hepatology, and Nutrition, University of Chicago, Chicago, Illinois, USA.
  • Parikh ND; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Hepatol Commun ; 7(3)2023 03 01.
Article em En | MEDLINE | ID: mdl-36881615
BACKGROUND: Patients with cirrhosis and subcentimeter lesions on liver ultrasound are recommended to undergo short-interval follow-up ultrasound because of the presumed low risk of primary liver cancer (PLC). AIMS: The aim of this study is to characterize recall patterns and risk of PLC in patients with subcentimeter liver lesions on ultrasound. METHODS: We conducted a multicenter retrospective cohort study among patients with cirrhosis or chronic hepatitis B infection who had subcentimeter ultrasound lesions between January 2017 and December 2019. We excluded patients with a history of PLC or concomitant lesions ≥1 cm in diameter. We used Kaplan Meier and multivariable Cox regression analyses to characterize time-to-PLC and factors associated with PLC, respectively. RESULTS: Of 746 eligible patients, most (66.0%) had a single observation, and the median diameter was 0.7 cm (interquartile range: 0.5-0.8 cm). Recall strategies varied, with only 27.8% of patients undergoing guideline-concordant ultrasound within 3-6 months. Over a median follow-up of 26 months, 42 patients developed PLC (39 HCC and 3 cholangiocarcinoma), yielding an incidence of 25.7 cases (95% CI, 6.2-47.0) per 1000 person-years, with 3.9% and 6.7% developing PLC at 2 and 3 years, respectively. Factors associated with time-to-PLC were baseline alpha-fetoprotein >10 ng/mL (HR: 4.01, 95% CI, 1.85-8.71), platelet count ≤150 (HR: 4.90, 95% CI, 1.95-12.28), and Child-Pugh B cirrhosis (vs. Child-Pugh A: HR: 2.54, 95% CI, 1.27-5.08). CONCLUSIONS: Recall patterns for patients with subcentimeter liver lesions on ultrasound varied widely. The low risk of PLC in these patients supports short-interval ultrasound in 3-6 months, although diagnostic CT/MRI may be warranted for high-risk subgroups such as those with elevated alpha-fetoprotein levels.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article